Crohn’s and Colitis Canada is introducing the country’s first national network of leading Crohn’s disease and ulcerative colitis patient care and research centres. Promoting Access and Care through Centres of Excellence (PACE) is the largest Canadian collaboration for adults living with Crohn’s disease and ulcerative colitis, the two main forms of inflammatory bowel disease (IBD).
“PACE unites centres of excellence to combine areas of expertise. It is a bold step forward to close gaps in Crohn’s disease and ulcerative colitis care,” says Mina Mawani, President and Chief Executive Officer, Crohn’s and Colitis Canada. “Working together, we will reduce chronic steroid use, expand access to inflammatory bowel disease specialists, empower patients and improve long-term outcomes.”
The PACE model is unique for Crohn’s and colitis care in Canada. PACE will facilitate a combination of independent research and collaborative learning over a four-year period. During the first year, each centre of excellence will drive its own research. The centres will then work collaboratively in order to develop their own competencies in all areas.
Recognizing the current gaps in care, Crohn’s and Colitis Canada chose to invest in five centres to support patient care. Together, they selected Dr. Geoffrey Nguyen, Clinician Scientist at Mount Sinai Hospital’s Centre of Excellence for Inflammatory Bowel Disease, which has one of Canada’s largest and most comprehensive multidisciplinary team of IBD clinicians, to spearhead PACE.
“We have the opportunity to better serve the quarter of a million Canadians living with Crohn’s disease and ulcerative colitis,” he says. “PACE provides a platform to share and strengthen our knowledge in order to improve patient outcomes.”
Dr. Nguyen is also one of the expert clinicians leading the centres in three provinces. – CNW